Mikkel Wandahl Pedersen
Mikkel Wandahl Pedersen publishes mostly in Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, on topics such as HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research and Lung Cancer Treatments and Mutations.
- World rank
- #629,427 of 7,710,434 ranked researchers
- Rank in Denmark
- #4,729 of 43,819
- Works
- 160
- Citations
- 3.2k
- Citations per work
- 19.8
What does Mikkel Wandahl Pedersen research?
Mikkel Wandahl Pedersen's work is mostly in Medicine (53%), Biochemistry, Genetics and Molecular Biology (16%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences8553.1%
- Medicine8553.1%
- Everything else4427.4%
- Life Sciences3119.5%
- 1Oncology31% of their works
- 2Radiology, Nuclear Medicine and Imaging15% of their works
- 3Molecular Biology12% of their works
- 4Pulmonary and Respiratory Medicine7% of their works
- 5Cancer Research4% of their works
- 6Immunology4% of their works
Research topics
Which keywords describe Mikkel Wandahl Pedersen's research?
The keywords of their largest research topics: Chemotherapy, Glycosylation, Breast Cancer, HER2, Targeted Therapy, Fc Receptors, Therapeutic Antibodies and Clinical Trials.
- Immunity
- Mutational Signatures
- Small-Cell Lung Cancer
- Genomic Profiles
- KRAS Mutations
- EGFR Mutations
- Clinical Trials
- Fc Receptors
- HER2
- Glycosylation
- Chemotherapy
- Breast Cancer
- Targeted Therapy
- Therapeutic Antibodies
- ALK Inhibitors
- Cetuximab
- Cancer
- Glycans
- Cancer Genomics
- Dendritic Cells
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Chemotherapy623 topics
- Glycosylation412 topics
- Breast Cancer371 topic
- HER2371 topic
- Targeted Therapy353 topics
- Fc Receptors311 topic
- Therapeutic Antibodies311 topic
- Clinical Trials272 topics
- ALK Inhibitors171 topic
- EGFR Mutations171 topic
- Cetuximab151 topic
- KRAS Mutations151 topic
- Cancer101 topic
- Genomic Profiles101 topic
- Glycans101 topic
- Small-Cell Lung Cancer101 topic
- Cancer Genomics81 topic
- Mutational Signatures81 topic
- Dendritic Cells61 topic
- Immunity61 topic
Where does Mikkel Wandahl Pedersen work?
Mikkel Wandahl Pedersen's main affiliation in the publication record is Symphogen (Denmark), Denmark.
How many publications and citations does Mikkel Wandahl Pedersen have?
OpenAlex counts 160 works and 3,162 citations for Mikkel Wandahl Pedersen, an h-index of 30, ranking #629,427 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mikkel Wandahl Pedersen. Posts are plain text and can be reported.